PRTK Annual EBIT
-$45.39 M
-$4.31 M-10.50%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual earnings before interest & taxes is -$45.39 million, with the most recent change of -$4.31 million (-10.50%) on December 31, 2022. During the last 3 years, it has risen by +$66.70 million (+59.50%).PRTK EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly EBIT
-$9.21 M
+$6.39 M+40.95%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly earnings before interest & taxes is -$9.21 million, with the most recent change of +$6.39 million (+40.95%) on June 30, 2023. Over the past year, it has increased by +$3.86 million (+29.51%).PRTK Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK TTM EBIT
-$43.71 M
+$3.86 M+8.11%
30 June 2023
Summary:
As of January 21, 2025, PRTK TTM earnings before interest & taxes is -$43.71 million, with the most recent change of +$3.86 million (+8.11%) on June 30, 2023. Over the past year, it has increased by +$23.90 million (+35.35%).PRTK TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.5% | +29.5% | +35.4% |
| 3 y3 years | +59.5% | +49.0% | +52.2% |
| 5 y5 years | +45.5% | +65.7% | +61.0% |
PRTK EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -3512.8% | -119.9% | -222.4% |
Paratek Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$9.21 M(-41.0%) | -$43.71 M(-8.1%) |
| Mar 2023 | - | -$15.61 M(+513.9%) | -$47.56 M(+4.8%) |
| Dec 2022 | -$45.39 M(+10.5%) | -$2.54 M(-84.4%) | -$45.39 M(-35.3%) |
| Sept 2022 | - | -$16.34 M(+25.0%) | -$70.11 M(+3.7%) |
| June 2022 | - | -$13.07 M(-2.7%) | -$67.60 M(+67.0%) |
| Mar 2022 | - | -$13.43 M(-50.7%) | -$40.47 M(-1.5%) |
| Dec 2021 | -$41.08 M(-46.2%) | -$27.26 M(+97.1%) | -$41.08 M(+22.4%) |
| Sept 2021 | - | -$13.84 M(-198.4%) | -$33.56 M(-5.2%) |
| June 2021 | - | $14.06 M(-200.2%) | -$35.40 M(-47.6%) |
| Mar 2021 | - | -$14.04 M(-28.9%) | -$67.55 M(-11.5%) |
| Dec 2020 | -$76.30 M(-31.9%) | -$19.74 M(+25.9%) | -$76.30 M(-3.4%) |
| Sept 2020 | - | -$15.68 M(-13.3%) | -$78.99 M(-13.5%) |
| June 2020 | - | -$18.09 M(-20.6%) | -$91.37 M(-10.9%) |
| Mar 2020 | - | -$22.79 M(+1.6%) | -$102.49 M(-8.6%) |
| Dec 2019 | -$112.09 M(+11.1%) | -$22.44 M(-20.0%) | -$112.09 M(+3.1%) |
| Sept 2019 | - | -$28.05 M(-4.0%) | -$108.75 M(-0.6%) |
| June 2019 | - | -$29.21 M(-9.8%) | -$109.39 M(+2.2%) |
| Mar 2019 | - | -$32.38 M(+69.6%) | -$107.01 M(+6.1%) |
| Dec 2018 | -$100.87 M(+21.2%) | -$19.10 M(-33.5%) | -$100.87 M(-1.4%) |
| Sept 2018 | - | -$28.70 M(+7.0%) | -$102.25 M(+9.4%) |
| June 2018 | - | -$26.83 M(+2.2%) | -$93.47 M(+12.7%) |
| Mar 2018 | - | -$26.24 M(+28.1%) | -$82.94 M(-0.4%) |
| Dec 2017 | -$83.24 M(-23.2%) | -$20.48 M(+2.8%) | -$83.24 M(-5.8%) |
| Sept 2017 | - | -$19.92 M(+22.2%) | -$88.36 M(-3.2%) |
| June 2017 | - | -$16.30 M(-38.6%) | -$91.25 M(-12.6%) |
| Mar 2017 | - | -$26.54 M(+3.7%) | -$104.41 M(-3.7%) |
| Dec 2016 | -$108.41 M(+54.7%) | -$25.60 M(+12.2%) | -$108.41 M(+5.0%) |
| Sept 2016 | - | -$22.81 M(-22.6%) | -$103.22 M(-0.5%) |
| June 2016 | - | -$29.46 M(-3.5%) | -$103.79 M(+15.3%) |
| Mar 2016 | - | -$30.54 M(+49.6%) | -$90.00 M(+28.4%) |
| Dec 2015 | -$70.09 M(+309.5%) | -$20.41 M(-12.7%) | -$70.09 M(+23.3%) |
| Sept 2015 | - | -$23.37 M(+49.1%) | -$56.84 M(+52.3%) |
| June 2015 | - | -$15.67 M(+47.4%) | -$37.34 M(+49.6%) |
| Mar 2015 | - | -$10.63 M(+48.5%) | -$24.96 M(+45.8%) |
| Dec 2014 | -$17.12 M(-29.9%) | -$7.16 M(+85.3%) | -$17.12 M(+10.6%) |
| Sept 2014 | - | -$3.87 M(+17.1%) | -$15.47 M(-5.0%) |
| June 2014 | - | -$3.30 M(+18.5%) | -$16.29 M(-2.6%) |
| Mar 2014 | - | -$2.79 M(-49.5%) | -$16.72 M(-31.5%) |
| Dec 2013 | -$24.41 M | -$5.52 M(+17.8%) | -$24.41 M(-3.9%) |
| Sept 2013 | - | -$4.69 M(+25.6%) | -$25.41 M(+60.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2013 | - | -$3.73 M(-64.4%) | -$15.82 M(-8.0%) |
| Mar 2013 | - | -$10.47 M(+60.7%) | -$17.19 M(+45.0%) |
| Dec 2012 | -$11.86 M(+215.0%) | -$6.52 M(-233.0%) | -$11.86 M(>+9900.0%) |
| Sept 2012 | - | $4.90 M(-196.1%) | -$10.00 K(-99.9%) |
| June 2012 | - | -$5.10 M(-0.9%) | -$9.87 M(+41.1%) |
| Mar 2012 | - | -$5.14 M(-196.5%) | -$7.00 M(+85.8%) |
| Dec 2011 | -$3.76 M(-59.2%) | $5.33 M(-207.4%) | -$3.76 M(-67.8%) |
| Sept 2011 | - | -$4.96 M(+123.5%) | -$11.68 M(+23.4%) |
| June 2011 | - | -$2.22 M(+16.2%) | -$9.46 M(+1.8%) |
| Mar 2011 | - | -$1.91 M(-26.2%) | -$9.29 M(+0.8%) |
| Dec 2010 | -$9.22 M(-53.5%) | -$2.59 M(-5.7%) | -$9.22 M(+3.8%) |
| Sept 2010 | - | -$2.74 M(+33.8%) | -$8.88 M(-11.4%) |
| June 2010 | - | -$2.05 M(+11.5%) | -$10.03 M(-34.2%) |
| Mar 2010 | - | -$1.84 M(-18.3%) | -$15.25 M(-23.2%) |
| Dec 2009 | -$19.85 M(+8.4%) | -$2.25 M(-42.2%) | -$19.85 M(-72.7%) |
| Sept 2009 | - | -$3.89 M(-46.5%) | -$72.70 M(-4.7%) |
| June 2009 | - | -$7.27 M(+12.9%) | -$76.26 M(+237.7%) |
| Mar 2009 | - | -$6.44 M(-88.3%) | -$22.58 M(+23.4%) |
| Dec 2008 | -$18.30 M(-50.1%) | -$55.10 M(+639.5%) | -$18.30 M(-155.7%) |
| Sept 2008 | - | -$7.45 M(-116.1%) | $32.88 M(-7.9%) |
| June 2008 | - | $46.41 M(-2250.4%) | $35.72 M(-230.4%) |
| Mar 2008 | - | -$2.16 M(-44.8%) | -$27.38 M(-25.3%) |
| Dec 2007 | -$36.65 M(+11.9%) | -$3.91 M(-15.3%) | -$36.65 M(-11.6%) |
| Sept 2007 | - | -$4.62 M(-72.3%) | -$41.46 M(-7.4%) |
| June 2007 | - | -$16.69 M(+46.1%) | -$44.76 M(+23.6%) |
| Mar 2007 | - | -$11.43 M(+31.0%) | -$36.20 M(+10.6%) |
| Dec 2006 | -$32.74 M(+31.7%) | -$8.72 M(+10.2%) | -$32.74 M(-33.1%) |
| Sept 2006 | - | -$7.92 M(-2.7%) | -$48.92 M(+19.3%) |
| June 2006 | - | -$8.13 M(+2.1%) | -$40.99 M(+24.8%) |
| Mar 2006 | - | -$7.97 M(-68.0%) | -$32.85 M(+32.1%) |
| Dec 2005 | -$24.86 M(+32.4%) | -$24.91 M(<-9900.0%) | -$24.86 M(+27.0%) |
| Sept 2005 | - | $14.00 K(0.0%) | -$19.58 M(+1.4%) |
| June 2005 | - | $14.00 K(0.0%) | -$19.31 M(+1.4%) |
| Mar 2005 | - | $14.00 K(-100.1%) | -$19.05 M(+1.4%) |
| Dec 2004 | -$18.78 M(-1512.0%) | -$19.62 M(-7106.8%) | -$18.78 M(-2335.6%) |
| Sept 2004 | - | $280.00 K(0.0%) | $840.00 K(+50.0%) |
| June 2004 | - | $280.00 K(0.0%) | $560.00 K(+100.0%) |
| Mar 2004 | - | $280.00 K | $280.00 K |
| Dec 2003 | $1.33 M(-122.6%) | - | - |
| Dec 2002 | -$5.88 M(+257.1%) | - | - |
| Dec 2001 | -$1.65 M | - | - |
FAQ
- What is Paratek Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual EBIT year-on-year change?
- What is Paratek Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly EBIT year-on-year change?
- What is Paratek Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals TTM EBIT year-on-year change?
What is Paratek Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of PRTK is -$45.39 M
What is the all time high annual EBIT for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual earnings before interest & taxes is $1.33 M
What is Paratek Pharmaceuticals annual EBIT year-on-year change?
Over the past year, PRTK annual earnings before interest & taxes has changed by -$4.31 M (-10.50%)
What is Paratek Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of PRTK is -$9.21 M
What is the all time high quarterly EBIT for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly earnings before interest & taxes is $46.41 M
What is Paratek Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, PRTK quarterly earnings before interest & taxes has changed by +$3.86 M (+29.51%)
What is Paratek Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of PRTK is -$43.71 M
What is the all time high TTM EBIT for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high TTM earnings before interest & taxes is $35.72 M
What is Paratek Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, PRTK TTM earnings before interest & taxes has changed by +$23.90 M (+35.35%)